88 related articles for article (PubMed ID: 18096875)
1. HGF increases cisplatin resistance via down-regulation of AIF in lung cancer cells.
Chen JT; Huang CY; Chiang YY; Chen WH; Chiou SH; Chen CY; Chow KC
Am J Respir Cell Mol Biol; 2008 May; 38(5):559-65. PubMed ID: 18096875
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor and HER2/neu downregulate expression of apoptosis-inducing factor in non-small cell lung cancer.
Chiang YY; Chow KC; Lin TY; Chiang IP; Fang HY
Oncol Rep; 2014 Feb; 31(2):597-604. PubMed ID: 24276579
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer.
Yamada T; Matsumoto K; Wang W; Li Q; Nishioka Y; Sekido Y; Sone S; Yano S
Clin Cancer Res; 2010 Jan; 16(1):174-83. PubMed ID: 20008840
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of apoptosis-inducing factor translocation is involved in protective effects of hepatocyte growth factor against excitotoxic cell death in cultured hippocampal neurons.
Ishihara N; Takagi N; Niimura M; Takagi K; Nakano M; Tanonaka K; Funakoshi H; Matsumoto K; Nakamura T; Takeo S
J Neurochem; 2005 Dec; 95(5):1277-86. PubMed ID: 16135073
[TBL] [Abstract][Full Text] [Related]
5. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking induces overexpression of hepatocyte growth factor in type II pneumocytes and lung cancer cells.
Chen JT; Lin TS; Chow KC; Huang HH; Chiou SH; Chiang SF; Chen HC; Chuang TL; Lin TY; Chen CY
Am J Respir Cell Mol Biol; 2006 Mar; 34(3):264-73. PubMed ID: 16254251
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of FAK and IAPs by laminin during cisplatin-induced apoptosis in testicular germ cell tumors.
Andjilani M; Droz JP; Benahmed M; Tabone E
Int J Oncol; 2006 Feb; 28(2):535-42. PubMed ID: 16391810
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
[TBL] [Abstract][Full Text] [Related]
9. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.
Phan LM; Fuentes-Mattei E; Wu W; Velazquez-Torres G; Sircar K; Wood CG; Hai T; Jimenez C; Cote GJ; Ozsari L; Hofmann MC; Zheng S; Verhaak R; Pagliaro L; Cortez MA; Lee MH; Yeung SC; Habra MA
Cancer Res; 2015 Oct; 75(19):4131-42. PubMed ID: 26282167
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
12. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
Liu LZ; Zhou XD; Qian G; Shi X; Fang J; Jiang BH
Cancer Res; 2007 Jul; 67(13):6325-32. PubMed ID: 17616691
[TBL] [Abstract][Full Text] [Related]
13. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
Mizuno S; Matsumoto K; Li MY; Nakamura T
FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer.
Gu T; Ohashi R; Cui R; Tajima K; Yoshioka M; Iwakami S; Sasaki S; Shinohara A; Matsukawa T; Kobayashi J; Inaba Y; Takahashi K
Lung Cancer; 2009 Nov; 66(2):176-83. PubMed ID: 19285749
[TBL] [Abstract][Full Text] [Related]
15. c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma.
Tokunou M; Niki T; Eguchi K; Iba S; Tsuda H; Yamada T; Matsuno Y; Kondo H; Saitoh Y; Imamura H; Hirohashi S
Am J Pathol; 2001 Apr; 158(4):1451-63. PubMed ID: 11290563
[TBL] [Abstract][Full Text] [Related]
16. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
[TBL] [Abstract][Full Text] [Related]
17. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.
Ma Y; Yuan RQ; Fan S; Hu C; Goldberg ID; Laterra JJ; Rosen EM
Anticancer Drugs; 2006 Aug; 17(7):733-51. PubMed ID: 16926624
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor-induced BMP-2 expression is mediated by c-Met receptor, FAK, JNK, Runx2, and p300 pathways in human osteoblasts.
Tsai SY; Huang YL; Yang WH; Tang CH
Int Immunopharmacol; 2012 Jun; 13(2):156-62. PubMed ID: 22504529
[TBL] [Abstract][Full Text] [Related]
19. Nuclear translocation of apoptosis inducing factor is associated with cisplatin induced apoptosis in LNCaP prostate cancer cells.
Zhang W; Zhang C; Narayani N; Du C; Balaji KC
Cancer Lett; 2007 Sep; 255(1):127-34. PubMed ID: 17560018
[TBL] [Abstract][Full Text] [Related]
20. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]